Aequus Pharmaceuticals is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange.
- A stock is considered undervalued if it trades at a discount to its valuation – a calculation used to determine the intrinsic (true) worth of a company
- Valuation methodology provided by Stockcalc (see below)
Drug Manufacturers: Major, global pharmaceutical manufacturers offering a broad and diverse line of drug and healthcare products; industry leaders that have made a significant commitment to the research and development of a long pipeline of drugs.
Stocks in this category are held primarily for capital appreciation.
| Symbol | Name | Close Price ($) | Valuation ($) | Difference | Average Vol (30D) | Market Cap ($M) | Yield (%) | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
| PCLO | PharmaCielo | 0.04 | 0.15 | 0.11 (239.7%) | 76738 | 7.7 | 0.0 | 0.0 |
| NAV | Navco Pharmaceuticals | 0.01 | 0.01 | 0.01 (166.0%) | 3633 | 0.0 | 0.0 | 0.0 |
| TLRY | Tilray Brands | 0.59 | 1.39 | 0.80 (135.4%) | 1260517 | 535.9 | 0.0 | 0.0 |
| AQS | Aequus Pharmaceuticals | 0.01 | 0.01 | 0.01 (129.2%) | 0.7 | 0.0 | 0.0 | |
| TSND | TerrAscend | 0.49 | 1.01 | 0.52 (105.4%) | 118262 | 143.6 | 0.0 | 35.4 |
| DB | Decibel Cannabis Co | 0.07 | 0.13 | 0.07 (101.5%) | 257153 | 37.5 | 0.0 | 2.2 |
| CURA | Curaleaf Holdings | 1.14 | 1.94 | 0.80 (70.4%) | 346956 | 849.2 | 0.0 | 0.0 |
| CANB | CanadaBis Cap | 0.05 | 0.08 | 0.03 (63.0%) | 86723 | 6.9 | 0.0 | 0.0 |
| LSL | LSL Pharma Group | 0.39 | 0.61 | 0.23 (59.7%) | 40433 | 40.6 | 0.0 | 12.8 |
| ROMJ | Rubicon Organics | 0.40 | 0.62 | 0.22 (55.0%) | 77991 | 23.4 | 0.0 | 0.0 |
All data provided as of June 15, 2025.
The list is sorted by stocks with the greatest percentage difference between valuation and price.
Aequus Pharmaceuticals
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products namely Tacrolimus IR and Vistitan.
Aequus Pharmaceuticals is listed under AQS on the TSX Venture Exchange.
Stockcalc
StockCalc is a Canadian fintech company specializing in fundamental valuations for North American stocks and ETFs.
Stockcalc valuations (https://www.stockcalc.com/Resources) can help determine if a stock is undervalued. Stockcalc’s Weighted Average Valuation (WAV) is based on a proprietary calculation using model and analyst inputs, including:
- Discounted Cash Flow (DCF)
- Price & Other Comparables
- Multiples
- Adjusted Book Value (ABV)
- Analyst Consensus
Artificial Intelligence at Report on Business
Report on Business scans market data using algorithms to process large quantities of information. The results are specialized reports produced through automation. Ongoing ROB project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities.
/AI%20(artificial%20intelligence)/3D%20Graphics%20Concept%20Big%20Data%20Center%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/Netflix%20on%20tv%20with%20remote%20by%20freestocks%20via%20Unsplash.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
